AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 83 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $835,330 | -24.6% | 81,100 | +20.7% | 0.01% | -35.0% |
| Q2 2023 | $1,107,341 | +4.7% | 67,193 | -41.8% | 0.02% | 0.0% |
| Q1 2023 | $1,058,017 | +168.7% | 115,504 | +110.0% | 0.02% | +233.3% |
| Q4 2022 | $393,800 | -91.0% | 55,000 | -89.9% | 0.01% | -87.8% |
| Q4 2021 | $4,391,000 | -38.2% | 543,400 | -25.0% | 0.05% | -39.5% |
| Q3 2021 | $7,105,000 | +1424.7% | 725,000 | +947.8% | 0.08% | +1250.0% |
| Q2 2021 | $466,000 | -45.4% | 69,192 | -26.5% | 0.01% | -68.4% |
| Q1 2021 | $853,000 | +99.8% | 94,192 | +11.3% | 0.02% | +90.0% |
| Q3 2020 | $427,000 | +5.4% | 84,600 | +69.2% | 0.01% | -23.1% |
| Q2 2020 | $405,000 | -87.8% | 50,000 | -88.0% | 0.01% | -93.0% |
| Q1 2020 | $3,313,000 | – | 417,200 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 4,133,464 | $45,592,000 | 5.54% |
| Stonepine Capital Management, LLC | 747,863 | $8,249,000 | 4.45% |
| JW Asset Management, LLC | 444,439 | $4,902,000 | 3.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $40,320,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 1,150,000 | $12,685,000 | 1.62% |
| FALCON POINT CAPITAL, LLC | 855,101 | $9,432,000 | 1.27% |
| Perceptive Advisors | 1,429,114 | $15,763,000 | 0.79% |
| KNOTT DAVID M | 126,463 | $1,395,000 | 0.58% |
| HEARTLAND ADVISORS INC | 700,000 | $7,721,000 | 0.50% |
| Sio Capital Management, LLC | 91,413 | $1,008,000 | 0.48% |